Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1022 participants.
Also called NCT05193071
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,022 participants
- Registry
-
NCT05193071
-
- Other papers using this trial's data
- Diabetes Mellitus and Early Antiplatelet Treatment for Minor Stroke Following Intravenous Thrombolysis: Prespecified Secondary Analysis of the EAST Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05193071. Randomized; quadruple masking; primary purpose treatment. Start 2022-07-08 (actual); primary completion 2024-10-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Aspirin 100mg; Clopidogrel 300mg
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct05193071- Content hash
71400ee830a780c909d13e17687e8caa4153187409c5317ce6d1ed906371c1b3